AI Biotech: Why Your Fastest Path Needs Academic Freedom
AI biotech is moving at light speed. Zera's Bo Wang and Ci Chu explain how to go faster by leaning on academic freedom and open science, not just industry muscle.
40 hours of podcasts, in 5 minutes.
This episode delves into Zera Therapeutics' AI drug discovery platform, focusing on their X-Cell model. Guests Bo Wang and Ci Chu explain how X-Cell leverages high-throughput causal data generation (Perturb-seq) and a novel diffusion model architecture with biological priors to predict cellular responses to interventions. They discuss the model's generalization capabilities to unseen biological contexts, the current bottlenecks in virtual cell modeling, and the evolving roles of academia and industry in AI for science.
AI biotech is moving at light speed. Zera's Bo Wang and Ci Chu explain how to go faster by leaning on academic freedom and open science, not just industry muscle.
Your virtual cell models hit a wall. Bo Wang and Ci Chu pinpoint the radical data breakthroughs needed for true temporal dynamics and functional insights.
Zera Therapeutics' X-Cell AI reframes gene prediction as iterative "editing," not typing. Learn how diverse biological priors unlock unseen generalization.
Zera Therapeutics' X-Cell AI just validated predictions in unseen biological contexts, proving true generalization. Founders: This is how AI redefines problem-solving.